News

The Catalan Minister of Health, Boi Ruiz, has inaugurated the new Laboratory of Metabolism and Cancer of IDIBELL.

The Bellvitge Biomedical Research Institute (IDIBELL) has recruited the researcher George Thomas, one of the leading international scientists in cancer and metabolic diseases.

Los investigadores hablan sobre dos estudios publicados en el mismo número de la revista, sobre la proteína quinasa mTOR, un regulador clave para la síntesis de las proteínas.

The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute (IDIBELL).